Allogeneic peripheral blood stem cell collection as of 2008

Transfusion and Apheresis Science

Volumn 38, Issue 3, 2008, Pages 219-227

  Rhodes, Beverly ^a   Anderlini, Paolo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Allogeneic stem cell transplantation; Filgrastim; G CSF; Granulocyte colony stimulating factor; Normal donors

Indexed keywords

CITRIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN S; HEPARIN; PLERIXAFOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AIR EMBOLISM; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ANTICOAGULATION; APHERESIS; ARTICLE; BONE PAIN; CAPILLARY LEAK SYNDROME; CD34 SELECTION; CHILL; DONOR; FEVER; FLU LIKE SYNDROME; HEADACHE; HEMOGLOBINOPATHY; HEMOLYSIS; HUMAN; INFORMED CONSENT; INSOMNIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTOSIS; MALAISE; MYALGIA; PATIENT SAFETY; SIDE EFFECT; SPLEEN RUPTURE; SPLENOMEGALY; STEM CELL MOBILIZATION; SWEATING; SYMPTOMATOLOGY; SYNCOPE; THROMBOCYTOPENIA; VASCULAR ACCESS; VOMITING;

BLOOD COMPONENT REMOVAL; DONOR SELECTION; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LIVING DONORS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 44949261875     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2008.04.011     Document Type: Article

References (50)

1. Horowitz M., and Confer L. Evaluation of hematopoietic stem cell donors. American society of hematology program book (2005) 469-475
2. Estey E., de Lima M., Tibes R., Pierce S., Kantarjian H., Champlin R., et al. Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Blood 109 (2007) 1395-1407
3. McSweeney P.A., Niederwieser D., Shizuru J.A., Sandmaier B.M., Molina A.J., Maloney D.G., et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97 (2001) 3390-3400
4. Pulsipher M.A., Nagler A., Iannone R., and Nelson R.M. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer 46 (2006) 422-433
5. Lane T.A., Ho A.D., Bashey A., Peterson S., Young D., and Law P. Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage- and granulocyte-colony-stimulating factors. Transfusion 39 1 (1999) 39-47
6. Liles W.C., Broxmeyer H.E., Rodger E., Wood B., Hübel K., Cooper S., et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102 (2003) 2728-2730
7. Arbona F., Prosper I., Benet F., Mena C., Solano M.C., and Garcia-Conde J. Comparison between once a day vs. twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBSC) in normal donors for allogeneic PBSC transplantation. Bone Marrow Transplant 22 (1998) 39-45
8. Kröger N., Sonnenberg S., Cortes-Dericks L., Freiberger P., Mollnau H., and Zander A.R. Kinetics of G-CSF and CD34+ cell mobilization after once or twice daily stimulation with rHu granulocyte-stimulating factor (lenograstim) in healthy volunteers: an intraindividual crossover study. Transfusion 44 (2004) 104-110
9. Martinez C., Urbano-Ispizua A., Marin P., Merino A., Rovira M., Carreras E., et al. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood cell mobilization in healthy donors. Bone Marrow Transplant 24 (1999) 1273-1278
10. Reddy R.L. Mobilization and collection of peripheral blood progenitor cells for transplantation. Transfus Apher Sci 32 1 (2005) 63-72
11. Anderlini P., Przepiorka D., Champlin R., and Körbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 88 (1996) 2819-2825
12. Höglund M., Smedmyr B., Simonsson B., Tötterman T., and Bengtsson M. Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF. Bone Marrow Transplant 18 (1996) 19-27
13. Grigg A.P., Roberts A.W., Raunow H., Houghton S., Layton J.E., Boyd A.W., et al. Optimizing dose and scheduling of filgrastim (granulocyte colony stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86 (1995) 4437-4445
14. Stroncek S., Shawker T., Follmann D., and Leitman S. G-CSF-induced spleen size changes in peripheral blood progenitor cell donors. Transfusion 43 5 (2003) 609-613
15. Höglund M., Smedmyr B., Bengtsson M., Totterman T.H., Cour-Chabernaud V., Yver A., et al. Mobilization of CD34+ cells by glycosylated and nonglycosylated GCSF in healthy volunteers: a comparative study. Eur J Haematol 59 (1997) 177-183
16. Hill G., Morris E., Fuery M., Hutchins C., Bultler J., Grigg A., et al. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylate G-CSF. Biol Blood Marrow Transplant 12 6 (2006) 603-607
17. Stroncek D.F., Clay M.E., Petzoldt M.L., Smith J., Jaszcz W., Oldham F.B., et al. Treatment of normal individuals with granulocyte-colony-stimulating factor. Donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 36 (1996) 601-610
18. Anderlini P., Donato M., Chan K.-W., Huh Y.O., Gee A.P., Lauppe M.J., et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 39 (1999) 555-560
19. Tigue C., McKoy J., Evens A., Trifilio S., Tallman M., and Bennett C. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant 40 (2007) 185-192
20. Platzbecker U., Prange-Krex G., Bornhäuser M., Koch R., Soucek S., Aikele P., et al. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion 41 2 (2001) 184-189
21. Confer DL. Adult allodonor stem cell collection safety issue from "Safeguarding adult and pediatric stem cell donors: basic science, clinical and ethical issues". Sheraton National Hotel, Arlington, VA, September 21-22; 2004.
22. Adler B.K., Salzman D.E., Carabasi M.H., et al. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood 97 (2001) 3313-3314
23. Wei A., and Grigg A. Granulocyte to colony-stimulating factor induced sicklecell crisis and multiorgan dysfunction in a patient with compound heterozygous sick cell/B+ thalassemia. Blood 97 (2001) 3998-3999
24. Gutiariez-Delgado F., and Bensinger W. Safety of granulocyte colony-stimulating factor in normal donors (hematopoietic growth factors). Curr Opin Hematol 8 (2001) 155-160
25. Tassi C., Tazzari P.L., Bonifazi F., Giudice V., Nannetti A., Ricci F., et al. Short-and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study. Bone Marrow Transplant 36 4 (2005) 289-294
26. Lysak D., Koza V., and Jindra P. Factors affecting PB SC mobilization and collection in healthy donors. Transfus Apher Sci 33 3 (2005) 275-283
27. Moncada V., Bolan C., Yau Y., and Leitman S. Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim. Transfusion 43 4 (2003) 495-501
28. Tomblyn M., Gordon L., Singhal S., Tallman M., Williams S., Winter J., et al. Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSF. Bone Marrow Transplant 36 (2005) 8-663
29. Kozuka T., Ikeda K., Teshima T., Yoshida C., Shinagawa K., Kojima K., et al. Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors. Transfusion 44 4 (2004) 526-532
30. Cassens U., Barth I., Baumann C., Fischer R., Kienast J., Vormoor J., et al. Factors affecting the efficacy of peripheral blood progenitor cells collections by large-volume leukapheresis with standardized processing volumes. Transfusion 44 (2004) 1593-1602
31. Rhodes B., and Sorensen S. Apheresis: an overview of procedures and need for vascular access devices. J Vas Access 9 4 (2004) 218-220
32. Anderlini P., Rizzo J.D., Nugent M.L., Schmitz N., Champlin R.E., and Horowitz M.M. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant 27 (2001) 689-692
33. Bolan C.D., Cecco S.A., Wesley R.A., Horne M., Yau Y.Y., Remaley A.T., et al. Controlled study of citrate effects and response to IV calcium administration during allogeneic peripheral blood progenitor cell donation. Transfusion 42 7 (2002) 935-946
34. McLeod B.C., Price T.H., Ciavarella O.D., Sniecinski I., Randels M.J., and Smith J.W. Frequency of immediate adverse effects associated with apheresis donation. Transfusion 38 (1998) 938-943
35. Falanga A., Marchetti M., Evangelista V., Manarini S., Oldani E., Giovanelli S., et al. Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor. Blood 93 8 (1999) 2506-2514
36. Topcuoglu P., Arat M., Dalva K., and Ozcan M. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors. Bone Marrow Transplant 33 2 (2004) 171-176
37. Suzuya H., Watanabe T., Nakagawa R., Watanabe H., Okamoto Y., Onishi T., et al. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang 89 4 (2005) 229-235
38. De la Rubia J., Arbona C., de Arriba F., del Cantildeizo C., Brunet S., Concha Z., et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 42 (2002) 4-9
39. Tichelli A., Passweg J., Hoffmann T., Gregor M., Kühne T., Favre G., et al. Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency. Br J Haematol 106 1 (1999) 152-158
40. Cecyn K.Z., Seber A., Ginani V.C., Goncalves A.V., Caram E.M., Oguro T., et al. Large volume leukapheresis for peripheral blood progenitor cell collection in low body weight pediatric patients: a single center experience. Transfus Apher Sci 32 3 (2005) 269-274
41. Marson P., Petris G., and Silvestro G. Collection of peripheral blood stem cells in pediatric patients: a concise review on technical aspects. Bone Marrow Transplant 20 (1997) 543-551
42. Malachowski M., Comenzo R., and Hillyer C. Large volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion 32 (1992) 732-735
43. Weiner, LS, Stefeen-Smith E, Battles HB, Wayne A, Love CP, Fry T. Sibling stem cell donor experiences at a single institution. Psycho-Oncology (in press). Published online www.interscience.wiley.com.
44. Sevilla J., Diaz M.A., Fernandez-Plaza S., Gonzalez-Vincent M., and Madero L. Risks and methods for peripheral blood progenitor cell collection in small children. Transfus Apher Sci 31 3 (2004) 221-231
45. Demetri G.D., and Griffin J.D. Granulocyte colony-stimulating factor and its receptor. Blood 78 (1991) 2791-2808
46. Anderlini P., Przepiorka D., Korbling M., and Champlin R. Blood and stem cell procurement. Donor safety issues. Bone Marrow Transplant 21 (1998) 35-39
47. Hasenclever D., and Sextro M. Safety of alloPBSCT donors: biometrical considerations on monitoring long term risks. Bone Marrow Transplant 17 Suppl. 2 (1996) 28-30
48. Bennett C.L., Evens A.M., Andritsos L.A., Balasubramanian L., Mai M., Fisher M.J., et al. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol 135 5 (2006) 651-652
49. Makita K., Ohta K., Mugitani A., Hagihara K., Ohta T., et al. Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest. Bone Marrow Transplant 33 (2004) 661-665
50. Confer D.L., and Miller J.P. Long-term safety of filgrastim (rhG-CSF) administration. Br J Haem (letter) 137 (2007) 77-78